Perrigo Company plc $PRGO Shares Purchased by SG Americas Securities LLC

SG Americas Securities LLC boosted its holdings in shares of Perrigo Company plc (NYSE:PRGO) by 1,495.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 134,433 shares of the company’s stock after buying an additional 126,008 shares during the quarter. SG Americas Securities LLC owned 0.10% of Perrigo worth $1,871,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC raised its stake in shares of Perrigo by 75.8% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 20,334 shares of the company’s stock valued at $300,000 after acquiring an additional 8,765 shares in the last quarter. GAMMA Investing LLC grew its stake in Perrigo by 112.6% during the 4th quarter. GAMMA Investing LLC now owns 6,194 shares of the company’s stock worth $86,000 after purchasing an additional 3,281 shares in the last quarter. Danske Bank A S purchased a new stake in Perrigo during the 3rd quarter worth about $53,000. Sherbrooke Park Advisers LLC acquired a new stake in Perrigo in the 3rd quarter valued at about $286,000. Finally, Lombard Odier Asset Management USA Corp boosted its stake in shares of Perrigo by 25.7% in the 3rd quarter. Lombard Odier Asset Management USA Corp now owns 98,106 shares of the company’s stock valued at $2,185,000 after buying an additional 20,040 shares during the period. Hedge funds and other institutional investors own 95.91% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently weighed in on PRGO shares. Jefferies Financial Group restated a “hold” rating on shares of Perrigo in a research note on Thursday, February 26th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Perrigo in a report on Monday, December 22nd. Argus raised shares of Perrigo to a “hold” rating in a research report on Wednesday, January 14th. Canaccord Genuity Group reduced their price objective on shares of Perrigo from $20.00 to $17.00 and set a “buy” rating on the stock in a report on Friday, February 27th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Perrigo from $20.00 to $18.00 and set a “neutral” rating for the company in a research report on Monday, December 15th. One equities research analyst has rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Reduce” and a consensus target price of $19.33.

Perrigo Stock Performance

Shares of PRGO opened at $10.84 on Monday. The stock has a 50 day moving average price of $12.31 and a 200 day moving average price of $15.16. The company has a quick ratio of 1.63, a current ratio of 2.76 and a debt-to-equity ratio of 1.23. The company has a market capitalization of $1.49 billion, a price-to-earnings ratio of -1.05, a price-to-earnings-growth ratio of 1.27 and a beta of 0.47. Perrigo Company plc has a 52-week low of $9.23 and a 52-week high of $28.43.

Perrigo (NYSE:PRGO) last released its quarterly earnings data on Thursday, February 26th. The company reported $0.77 earnings per share for the quarter, missing analysts’ consensus estimates of $0.80 by ($0.03). Perrigo had a positive return on equity of 9.41% and a negative net margin of 33.51%.The company had revenue of $1.11 billion for the quarter, compared to analyst estimates of $1.09 billion. During the same period in the previous year, the business posted $0.93 EPS. The firm’s revenue for the quarter was down 2.5% compared to the same quarter last year. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Research analysts predict that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 24th. Investors of record on Monday, March 2nd were given a $0.29 dividend. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $1.16 dividend on an annualized basis and a yield of 10.7%. Perrigo’s payout ratio is -11.28%.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.